Near-Infrared Photobiomodulation Therapy (NIR-PBMT) has been deemed a safe and effective non-invasive treatment for age-related erectile dysfunction (ARED), leading to the decision to initiate controlled clinical trials to confirm its efficacy and safety in human subjects. The therapy's ability to reverse damaging physiological changes and enhance endothelial function in erectile tissues positions it as a transformative option for aging populations grappling with ARED.